Europe Laboratory Animal Diets Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Diet Type (Standard Diets, Irradiated Diets, and Autoclavable Diets), Animal (Mouse, Cat, Dog, Rabbit, Chicken, and Others), Application (Drug Discovery & Personalized Medicine, Regenerative Medicine, Pathology of Infectious Diseases, Drug Toxicity & Efficacy Testing, and Others), and End User (Pharmaceutical & Biopharmaceutical Companies, Research & Academic Institutes, and Others)
The laboratory animal diets market in Europe is expected to grow from US$ 1,390.14 million in 2022 to US$ 1,882.51 million by 2028; it is estimated to grow at a CAGR of 5.3% from 2022 to 2028.
Growing Consumption of Personalized Medicines Fuel Europe Laboratory Animal Diets Market
The application of personalized medicine depends heavily on the availability of rigorous diagnostic tools that allow the optimal selection of therapeutic products to improve patient outcomes. According to the Food and Drug Administration (FDA), personalized medicine aims to provide benefits that reduce patient risks by targeting prevention and treatment more effectively. The field of personalized medicine predicts the human response to medicines and diseases based on intraspecific differences. Researchers help in developing approaches to personalized medicines for many genetic disorders. These personalized medicines use custom genetic interventions such as antisense-mediated exon skipping or genome editing to restore protein function in a mutation-specific manner. In drug discovery and development, mice models have played an essential role by characterizing disease pathophysiology and associated injury mechanisms; identifying drug targets; and evaluating novel therapeutics for toxicity/safety, pharmacokinetics, pharmacodynamics, and efficacy. Animal models can facilitate the development of personalized medicine approaches. Personalized medicine approaches need to be developed and preclinically tested in relevant cell and mouse models that ideally contain the human target sequences. The animal models used for personalized medicine research and drug discovery & development are provided with specific diets so that the animal model will react according to the human environment. Therefore, with the rising demand for personalized medicines, the laboratory animal diet market is growing substantially across Europe.
Market Overview
The Europe laboratory animal diets market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. The market growth is attributed to the growing demand for animal models to study nutrition-related problems. Additionally, the rising production of animal models by pharmaceutical companies to study treatment for rare diseases such as osteoarthritis and cardiomyopathy is likely to create opportunities for the market players in the coming years. In Germany, pigs are the most used animal models for the clinical validation of drugs and medical devices. Their similarity to humans in terms of physiology, genetics, and anatomy is driving the demand for pig models. For instance, in 2020, the German Centre for Diabetes Research used pig models to examine organ crosstalk and complications in diabetes mellitus. In addition, a rise in the application of pigs as animal models in research activity is contributing to the market growth. Thus, the increasing use of animals for experimental purposes is contributing to the growth of the laboratory animal diet market.
Europe Laboratory Animal Diets Market Revenue and Forecast to 2028 (US$ Million)
Europe Laboratory Animal Diets Market Segmentation
The Europe laboratory animal diets market is segmented into diet type, animal, application, end user, and country.
Based on diet type, the market is segmented into standard diets, irradiated diets, and autoclavable diets. The standard diets segment registered the largest market share in 2022.
Based on animal, the Europe laboratory animal diets market is segmented into mouse, cat, dog, rabbit, chicken, and others. The mouse segment registered the largest market share in 2022.
Based on application, the Europe laboratory animal diets market is segmented into drug discovery and personalized medicines, regenerative medicines, pathology of infectious disease, drug toxicity and efficacy testing, and others. The drug discovery and personalized medicine segment registered the largest market share in 2022.
Based on end user, the Europe laboratory animal diets market is segmented into pharmaceutical & biopharmaceutical companies, research & academic institutes, and others. The pharmaceutical & biopharmaceutical companies segment registered the largest market share in 2022.
Based on country, the Europe laboratory animal diets market is segmented into the UK, Germany, France, Italy, Spain, and the Rest of Europe. Germany dominated the market in 2022.
Altromin Spezialfutter GmbH & Co. KG, Bio-Serv, Envigo, Krishna Valley Agrotech LLP, LabDiet, Research Diets Inc., SAFE, Special Diet Services, and Specialty Feeds are the leading companies operating in the laboratory animal diets market in Europe.
Reasons to Buy
Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America GPU database market.
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the North America GPU database market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth North America market trends and outlook coupled with the factors driving the GPU database market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook